Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.670
-0.050 (-2.91%)
Feb 21, 2025, 4:00 PM EST - Market closed
Phio Pharmaceuticals Employees
As of December 31, 2023, Phio Pharmaceuticals had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$824,333
Market Cap
5.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
PHIO News
- 3 days ago - Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors - Newsfile Corp
- 20 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile Corp
- 4 weeks ago - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile Corp
- 4 weeks ago - Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 5 weeks ago - Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why - Benzinga